| P2093 | author name string | Maarten E A Reith | |
| | Bo-Jin Cao | |
| P2860 | cites work | Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. | Q31744806 |
| | The reverse transport of DA, what physiological significance? | Q31804333 |
| | Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. | Q31962185 |
| | Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study | Q33960234 |
| | Diazeniumdiolates: pro- and antioxidant applications of the "NONOates". | Q33991762 |
| | Nitric oxide: a novel link between synaptic and nonsynaptic transmission | Q34183621 |
| | Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms | Q34621009 |
| | Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation | Q35042437 |
| | Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity | Q37683630 |
| | Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. | Q40728188 |
| | In vitro cytotoxicity of glyco-S-nitrosothiols. a novel class of nitric oxide donors | Q40802987 |
| | Nitric oxide induces differentiation in the NB69 human catecholamine-rich cell line | Q40858367 |
| | Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. | Q41012269 |
| | Metabolism of Catecholamines by Catechol‐O‐Methyltransferase in Cells Expressing Recombinant Catecholamine Transporters | Q41084591 |
| | The protective role of thiols against nitric oxide-mediated cytotoxicity in murine macrophage J774 cells | Q41127122 |
| | Regulation by phorbol esters of the glycine transporter (GLYT1) in glioblastoma cells | Q41379110 |
| | Release of dopamine via the human transporter | Q41492245 |
| | Comparative effects of several nitric oxide donors on intracellular cyclic GMP levels in bovine chromaffin cells: correlation with nitric oxide production | Q41884025 |
| | Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes. | Q42493248 |
| | Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter | Q42552999 |
| | Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures | Q43516525 |
| | Dendrodendritic inhibition through reversal of dopamine transport | Q43751067 |
| | Nitric oxide induces neurotransmitter release from hippocampal slices | Q44987939 |
| | 3Hsubstrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux | Q47684824 |
| | Nitric oxide inhibits [3H]dopamine uptake. | Q48154715 |
| | Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. | Q48186330 |
| | Spermine interacts with cocaine binding sites on dopamine transporters | Q48186433 |
| | Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms | Q48251443 |
| | Nitric oxide induces calcium-dependent [3H]dopamine release from striatal slices | Q48279967 |
| | Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures | Q48281625 |
| | Opposite effects of spermine and arcaine on responses of receptors expressed in Xenopus oocytes | Q48624759 |
| | Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines | Q48635729 |
| | High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport | Q48789845 |
| | Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate | Q50531656 |
| | The use of nitric oxide donors in pharmacological studies | Q53947007 |
| | Modulation of In Vivo Striatal Transmitter Release by Nitric Oxide and Cyclic GMP | Q59925970 |
| | Concurrent Autoreceptor-Mediated Control of Dopamine Release and Uptake during Neurotransmission: AnIn VivoVoltammetric Study | Q64013206 |
| | Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential mechanisms of nitric oxide-mediated neurotoxicity | Q71499610 |
| | The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro | Q72578383 |
| | Ion channels in glial cells | Q73666122 |
| | Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. I: Requirement to antioxidants in the medium | Q74097498 |
| | Transport and drug binding kinetics in membrane vesicle preparation | Q77435050 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1155-1162 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter | |
| P478 | volume | 137 | |